Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/4/2010

as compared to a net loss of $31.0 million or $0.33 per share in the third quarter of 2009.

Conference Call to Discuss Third Quarter 2010 Financial ResultsA conference call to review the financial results will be held today, Thursday, November 4, 2010 at 2 PM Pacific Time.  

Details are below:

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Friday, November 19, 2010. To access the conference call, follow these instructions:Dial: (800) 798-2864 (U.S.); (617) 614-6206 (international)Passcode: 87996589 (Nektar is the host)An audio replay will also be available shortly following the call through Friday, November 19, 2010 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 55049373.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for Nektar's oral NKTR-118 development program to treat opioid-induced constipation and its NKTR-119 development program for the treatment of pain without constipation side effects. The company has additional pain compounds in prec
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... The report "Silage Inoculants & ... Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & ... Inoculants & Enzymes Market is expected to reach $489.05 ... 2015 to 2020. Browse 75 market ... P ages and an in-depth TOC ...
(Date:7/2/2015)... -- Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Technologica Ltda., an X-ray system equipment manufacturer based in ... Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... significant healthcare technical advancements and efficiencies are required. Aging ...
(Date:7/2/2015)... de julio de 2015 BGI anunció hoy ... alto rendimiento en Hong Kong ... Pathologists (CAP). La instalación de BGI en Hong ... de próxima generación que recibe la certificación CAP en ... estándar en prácticas de laboratorio clínico. Junto con el ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3BGI recibe la acreditación del College of American Pathologists (CAP) 2
(Date:7/2/2015)... ... July 02, 2015 , ... The ZAC Foundation, a national leader ... with important lessons on how to stay water safe with the help of a ... authored by The ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, who ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... provides comprehensive information on the pipeline products with comparative analysis of the ... therapy (NPWT) with 22 market data tables and 4 figures, spread across ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... them with care and precision. There is an art and science that goes ... honor of successfully reshaping the facial features and lives of more than 2,500 ...
(Date:7/2/2015)... ... 02, 2015 , ... Octo Consulting Group, (Octo), a leading ... has announced they are among nine contractors awarded the U.S. Securities and Exchange ... not to exceed $250 million. , To achieve the goals of the ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman Digital Anatomy, ... release of their flagship product, 3D Tooth Atlas, version 7.6. This release delivers ... new tutorial videos. This latest release of the 3D Tooth Atlas offers a ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2
... National ... Immunization Awareness Month, NORTH HAVEN, Conn., Sept. 6 In ... in,Connecticut is reminding parents to make sure their adolescents,immunizations are up ... the perfect time for parents to check with their child,s provider,to ...
... Hospital Directory show new rules issued by the Centers, for ... rural hospitals and hospitals specializing in cardiac care. ... changes in outlier payment are also forecasted., ... Services (CMS) has issued the most sweeping rule,changes for hospital ...
... IV product a proven treatment -, BELLEVILLE, ... (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today ... to Australia in order to be able to ... that continent,s equine influenza outbreak.,The outbreak began in ...
... of women with breast cancer stopped taking a commonly ... to a new study from researchers at the University ... the study were taking aromatase inhibitors, a type of ... fuels some breast cancers. The treatment is generally given ...
... LOUISVILLE, Ky., Sept. 5 Ventas, Inc. (NYSE:,VTR) ("Ventas" ... Directors,declared a regular quarterly dividend of $0.475 per share, ... record on September 17, 2007. The,dividend is the third ... dividend. Ventas, Inc. is a leading healthcare real ...
... a,wholly owned subsidiary of Siemens Corporation, announced today that ... offer for all outstanding,shares of common stock of Dade ... has been extended to 12:00 Midnight, New York City ... being made pursuant to,an Agreement and Plan of Merger, ...
Cached Medicine News:Health News:Immunizations Part of Back to School Preparations 2Health News:Immunizations Part of Back to School Preparations 3Health News:Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 3Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 2Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 4Health News:Siemens Extends Tender Offer for Acquisition of Dade Behring 2
... for convenient pH catheter calibration., ,pH catheters ... procedure. The Alpine Calibration kit contains disposable ... for your convenience. Simply cut the end ... to soak. No measuring or pouring! Available ...
Bravo Datalink. For upload of Bravo pH data to a PC. Connects to the pcs serial port....
Bravo Tubing/Filter Supplies (Ten tubing sets, ten filters)...
Stand with buffer tubes for calibration of Bravo pH capsule....
Medicine Products: